IBM Watson moves into China to improve cancer treatment : fiercebiotech

according to fiercebiotech

IBM Watson moves into China to improve cancer treatment

IBM Watson moves into China to improve cancer treatment

Twenty-two hospitals in China will adopt IBM's Watson in a multiyear push toward personalized and evidence-based cancer treatment.In its first partnership in China, IBM will work with healthcare services organization Hangzhou CognitiveCare to introduce Watson for Oncology to hospitals across the country.Hangzhou CognitiveCare will support the Watson rollout in China by localizing Watson for Oncology.For example, because Watson will initially only be available in English, CognitiveCare will offer translation support so that insights, such as drug labels and treatment guidelines, will be available to customers and patients in Chinese, according to a statement.


in the same way fiercebiotech

IBM Watson moves into China to improve cancer treatment

IBM Watson moves into China to improve cancer treatment

Twenty-two hospitals in China will adopt IBM's Watson in a multiyear push toward personalized and evidence-based cancer treatment.In its first partnership in China, IBM will work with healthcare services organization Hangzhou CognitiveCare to introduce Watson for Oncology to hospitals across the country.Hangzhou CognitiveCare will support the Watson rollout in China by localizing Watson for Oncology.For example, because Watson will initially only be available in English, CognitiveCare will offer translation support so that insights, such as drug labels and treatment guidelines, will be available to customers and patients in Chinese, according to a statement.


let alone thedrum

IBM's Watson will be used in 21 Chinese hospitals to aid cancer treatment

IBM's Watson will be used in 21 Chinese hospitals to aid cancer treatment

IBM's artificial intelligence technology Watson has signed a deal with Hangzhou CognitiveCare in China to implement Watson for Oncology.The deal will see doctors in China use the service to create personalised, evidence-based cancer treatment options.The Watson for Oncology service is able to work because Memorial Sloan Kettering has trained the AI, creating a cognitive computer programme.It works by analysing big volumes of medical literature to identify individual treatment options as well as scoring and ranking medical literature and quickly summarizing patient records.